Tuesday, March 9, 2021

Market cap of MetLife Inc. [MET] reaches 49.49B – now what?

Must read

A look IntoAtomera Incorporated (ATOM)

Atomera Incorporated (NASDAQ: ATOM) has announced the successful sale of one of its development projects.  ATOM stock was last closed at $25.27. Based on...

MetLife Inc. [NYSE: MET] closed the trading session at $56.07 on 02/19/21. The day’s price range saw the stock hit a low of $55.35, while the highest price level was $56.2518. The company report on February 17, 2021 that MetLife Announces First Quarter 2021 Preferred Stock Dividend Actions.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Declares Series C, D, E, F and G Preferred Stock Dividends.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Declares Series A Preferred Stock Dividend, Subject to Final Confirmation.

The stocks have a year to date performance of 19.42 percent and weekly performance of 1.37 percent. The stock has been moved at 46.78 percent over the last six months. The stock has performed 8.56 percent around the most recent 30 days and changed 21.86 percent over the most recent 3-months.

If compared to the average trading volume of 5.55M shares, MET reached to a volume of 4791930 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about MetLife Inc. [MET]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $56.55 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Piper Sandler have made an estimate for MetLife Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on January 06, 2021. While these analysts kept the previous recommendation, Citigroup raised their target price from $39 to $55. The new note on the price target was released on December 08, 2020, representing the official price target for MetLife Inc. stock. Previously, the target price had yet another raise to $48, while Goldman analysts kept a Neutral rating on MET stock.

The Average True Range (ATR) for MetLife Inc. is set at 1.28, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.73. The Price to Book ratio for the last quarter was 0.68, with the Price to Cash per share for the same quarter was set at 22.43. Price to Free Cash Flow for MET in the course of the last twelve months was 4.96.

MET stock trade performance evaluation

MetLife Inc. [MET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.37. With this latest performance, MET shares gained by 8.56% in over the last four-week period, additionally plugging by 46.78% over the last 6 months – not to mention a rise of 7.25% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 70.79, with the RSI for the last a single of trading hit 73.18, and the three-weeks RSI is set at 68.65 for MetLife Inc. [MET]. The present Moving Average for the last 50 days of trading for this stock 49.68, while it was recorded at 55.63 for the last single week of trading, and 41.51 for the last 200 days.

MetLife Inc. [MET]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and MetLife Inc. [MET] shares currently have an operating margin of +11.92. MetLife Inc.’s Net Margin is presently recorded at +7.97.

Return on Total Capital for MET is now 9.13, given the latest momentum, and Return on Invested Capital for the company is 6.15. Return on Equity for this stock inclined to 7.69, with Return on Assets sitting at 0.70. When it comes to the capital structure of this company, MetLife Inc. [MET] has a Total Debt to Total Equity ratio set at 25.48. Additionally, MET Total Debt to Total Capital is recorded at 20.30, with Total Debt to Total Assets ending up at 2.39. Long-Term Debt to Equity for the company is recorded at 24.95, with the Long-Term Debt to Total Capital now at 19.88.

Reflecting on the efficiency of the workforce at the company, MetLife Inc. [MET] managed to generate an average of $116,280 per employee.

Earnings per share (EPS) analysis for MetLife Inc. [MET] stock

With the latest financial reports released by the company, MetLife Inc. posted 1.58/share EPS, while the average EPS was predicted by analysts to be reported at 1.44/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 9.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MetLife Inc. go to 4.20%.

MetLife Inc. [MET]: Insider Ownership positions

There are presently around $37,033 million, or 77.10% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: DODGE & COX with ownership of 66,215,913, which is approximately -0.791% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 64,209,500 shares of the stock with an approximate value of $3.6 billion in MET stocks shares; and VANGUARD GROUP INC, currently with $3.35 billion in MET stock with ownership of nearly -2.036% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in MetLife Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 452 institutional holders increased their position in MetLife Inc. [NYSE:MET] by around 35,124,481 shares. Additionally, 500 investors decreased positions by around 46,456,022 shares, while 150 investors held positions by with 578,891,228 shares. The mentioned changes placed institutional holdings at 660,471,731 shares, according to the latest SEC report filing. MET stock had 139 new institutional investments in for a total of 5,763,216 shares, while 64 institutional investors sold positions of 2,801,381 shares during the same period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

A look IntoAtomera Incorporated (ATOM)

Atomera Incorporated (NASDAQ: ATOM) has announced the successful sale of one of its development projects.  ATOM stock was last closed at $25.27. Based on...

Armstrong Flooring Inc (AFI) Hitting the mark

Armstrong Flooring Inc (AFI) ‎stock got some oxygen when the company publicly announced to sell its production facility and real state property of theSouth...

The Goodyear Tire & Rubber Company (GT): Keeping an Eye On The Long Term

The Goodyear Tire & Rubber Company (NASDAQ: GT) has acquired rival Cooper Tire & Rubber Company (NYSE: CTB) for $2.8 billion. The takeover will...

OCUL stock: Ocular Therapeutix (OCUL) Is Better Than You Think

Ocular Therapeutix (OCUL) has performed well over the past year. OCUL has experienced a 248.76% gain in the last year, while its stock has...

Examining the Technicals of Levi Strauss & Co (NYSE: LEVI)

Levi Strauss & Co (NYSE: LEVI), one of the world's most famous denim brands, is recovering from the COVID-19 crisis. As a result of...

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.